Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Reaches New 52-Week Low at $9.33

Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOY) reached a new 52-week low during trading on Monday . The company traded as low as $9.33 and last traded at $9.58, with a volume of 383951 shares. The stock had previously closed at $9.71.

Shionogi & Co., Ltd. Trading Down 0.5 %

The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.37 and a current ratio of 5.86. The firm has a market cap of $11.34 billion, a PE ratio of 9.91, a PEG ratio of 2.71 and a beta of 0.21. The stock’s 50 day simple moving average is $10.81 and its 200 day simple moving average is $11.74.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) last released its quarterly earnings results on Monday, May 13th. The company reported $0.21 EPS for the quarter. Shionogi & Co., Ltd. had a net margin of 37.29% and a return on equity of 13.20%. The business had revenue of $662.08 million during the quarter. On average, sell-side analysts forecast that Shionogi & Co., Ltd. will post 0.87 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.